Dublin, May 07, 2026 (GLOBE NEWSWIRE) — The “Elemental Analysis Market by Type, Technique, End User – Global Forecasts to 2030” has been added to ResearchAndMarkets.com’s offering.
The elemental analysis market is projected to experience significant growth, increasing from USD 4.51 billion in 2025 to USD 6.48 billion by 2030, at a CAGR of 7.4%.
This growth is driven by various regulatory, technological, and industrial factors. Increased awareness of health risks related to toxic metals like lead, arsenic, cadmium, and mercury has led to stricter regulations, demanding precise analytical methods from industries. Regulatory bodies such as the FDA, EPA, and REACH have set stringent testing standards, compelling industries to adopt reliable testing solutions.
Technological advancements, including ICP-OES, ICP-MS, and automated elemental analyzers, have enhanced testing accuracy and efficiency, facilitating regulatory compliance. The surge in environmental contamination due to rapid industrialization and urbanization in emerging economies has escalated the demand for routine elemental and heavy metal monitoring. Consumer demand for contaminant-free products in healthcare and personal care further boosts the adoption of advanced testing solutions, contributing to market expansion globally.
Leading companies involved include Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bruker Corporation, PerkinElmer Inc., Shimadzu Corporation, SPECTRO Analytical Instruments GmbH, HORIBA Ltd., Analytik Jena AG, and others. These players are influential in shaping the market dynamics through cutting-edge technology and strategic initiatives.
ICP-OES holds the largest market share due to its superior performance in multi-element detection. With high sensitivity and precision, ICP-OES is ideal for applications in pharmaceuticals, environmental monitoring, and food safety. Its capability to handle elements at varying concentrations eliminates the need for multiple instruments, making it cost-effective and efficient. Regulatory approval of ICP-OES methods by pharmacopeias and environmental authorities supports its extensive adoption, ensuring its dominance in the elemental analysis market.
Pharmaceutical and biopharmaceutical companies lead the market owing to the critical need for monitoring elemental impurities in drug products. Regulatory guidelines such as ICH Q3D and USP 232 enforce limits on toxic metals in medications. Biopharmaceuticals require detailed elemental profiling to ensure safety and consistency. The complexity of drug formulations and outsourcing trends to CROs drive the demand for high-precision analytical instruments, reinforcing the sector’s significant market share globally.
Asia-Pacific to exhibit the highest CAGR during the forecast period.
Although North America currently leads the market due to advanced regulatory frameworks and infrastructure, Asia-Pacific is set to grow rapidly. Factors such as industrialization, expanding pharmaceutical and biotechnology sectors, and increased healthcare investment drive this growth. Countries like China, India, and South Korea are enhancing their drug production capabilities and adopting advanced analytical instruments, which boosts the region’s demand for testing solutions, thus positioning Asia-Pacific as a leading market segment.
Research Coverage and Benefits
- Comprehensive study of the elemental analysis market based on brand, product type, procedure, end user, and region.
- Analysis of market growth factors, opportunities, and competitive landscape.
- Insights on promising markets and competitive assessments of major industry players.
- Discussion on key market drivers, restraints, opportunities, and challenges.
- In-depth analysis of product development, market diversification, and technological innovations.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 248 |
| Forecast Period | 2025 – 2030 |
| Estimated Market Value (USD) in 2025 | $4.51 Billion |
| Forecasted Market Value (USD) by 2030 | $6.48 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Stringent Global Environmental and Food-Safety Regulations
- Rising Public Health Burden and Contamination Events
- Expansion of Industrial and Resource-Extraction Activities
- Shift Toward Outsourced Testing and Accredited Labs
Restraints
- High Capital and Operating Costs
- Shortage of Skilled Analytical Workforce
- Limited Laboratory Infrastructure in Emerging Economies
Opportunities
- Rising Demand in Emerging Economies
- Expanding Global Water Quality Monitoring Mandates
Challenges
- High Cost of Advanced Analytical Instruments
- Regulatory Complexity and Variation
- Sample Contamination and Accuracy Concerns
Company Profiles
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Bruker
- Perkinelmer
- Shimadzu Corporation
- Spectro Analytical Instruments GmbH
- Analytik Jena GmbH+Co. KG
- Horiba
- Elementar Analysensysteme GmbH
- Gbc Scientific Equipment Pty Ltd. (Gbcsci)
- Skyray Instruments, Inc.
- Malvern Panalytical Ltd.
- Rigaku Holdings Corporation
- Leco Corporation
- Advion, Inc.
- Teledyne Technologies Incorporated
- Hitachi, Ltd.
- Alpha Measurement Solutions LLC
- Buck Scientific Instruments LLC
- Jeol Ltd.
- Pg Instruments
- Labindia Instruments Pvt. Ltd.
- Aurora Biomed Inc.
- Beijing Beifen-Ruili Analytical Instrument (Group)
- Sciaps, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/nuzf5v
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Elemental Analysis Market
